aTyr Pharma Cash from Financing (TTM) Trends

aTyr Pharma Inc (LIFE)

1.585 -0.01 (-0.63%) USD | NASDAQ | Apr 26, 14:58

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	66.23M
September 30, 2023	61.11M
June 30, 2023	61.44M
March 31, 2023	53.47M
December 31, 2022	5.451M
September 30, 2022	4.561M
June 30, 2022	85.42M
March 31, 2022	86.65M
December 31, 2021	110.02M
September 30, 2021	111.00M
June 30, 2021	27.46M
March 31, 2021	24.22M
December 31, 2020	16.14M
September 30, 2020	13.15M
June 30, 2020	12.69M
March 31, 2020	18.73M
December 31, 2019	1.336M
September 30, 2019	1.718M
June 30, 2019	-0.154M

Date	Value
March 31, 2019	-4.865M
December 31, 2018	-4.238M
September 30, 2018	2.537M
June 30, 2018	47.03M
March 31, 2018	52.71M
December 31, 2017	52.70M
September 30, 2017	54.69M
June 30, 2017	11.33M
March 31, 2017	5.525M
December 31, 2016	4.697M
September 30, 2016	-3.549M
June 30, 2016	-3.473M
March 31, 2016	102.02M
December 31, 2015	147.92M
September 30, 2015	147.23M
June 30, 2015	147.24M
March 31, 2015	47.57M
December 31, 2014	2.512M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.154M

Minimum

Jun 2019

111.00M

Maximum

Sep 2021

40.03M

Average

24.22M

Median

Mar 2021

Cash from Financing (TTM) Benchmarks